Literature DB >> 10921583

Antioxidant enzymes are induced during recovery from acute lung injury.

R A Kozar1, C J Weibel, J Cipolla, A J Klein, M M Haber, M Z Abedin, S Z Trooskin.   

Abstract

OBJECTIVE: To determine the contribution of the pulmonary antioxidant defense enzymes of the hexose monophosphate (HMP) shunt and glutathione systems to recovery from oxidant-mediated lung injury in an animal model shown to closely resemble the clinical syndrome of acute respiratory distress syndrome.
DESIGN: Prospective, controlled laboratory study on phorbol myristate acetate (PMA)-induced lung injury in rabbits.
SETTING: Animal research laboratory.
SUBJECTS: Rabbits were injected with PMA (80 microg/kg) for 3 consecutive days. Control animals received normal saline.
MEASUREMENTS AND MAIN RESULTS: Lungs were harvested at 24, 48, 72, and 96 hrs (n = 5/time point) after PMA injection or after the third injection of normal saline in control animals (n = 6). The cytosolic fraction from lung and bronchial alveolar lavage (BAL) fluid was used for measurements of HMP shunt and glutathione enzymes. Pulmonary activity peaked at 48 hrs post-PMA injury with a 40% increase in glucose-6-phosphate dehydrogenase activity and a 32% increase in 6-phosphogluconate dehydrogenase activity over control levels. BAL activity was maximal at 72 hrs with an increase of 98% in glucose-6-phosphate dehydrogenase and 346% in 6-phosphogluconate dehydrogenase activities. Glutathione peroxidase was maximally induced by 77% at 48 hrs in BAL and by 107% at 24 hrs in lung. Glutathione reductase activity did not increase significantly in either lung or BAL.
CONCLUSIONS: The observed induction of the antioxidant enzymes in response to PMA suggests that both the HMP shunt and the glutathione systems contribute to the recovery phase of oxidant-mediated lung injury. The inability of natural host defenses to regenerate reduced glutathione may explain failure of recovery from acute respiratory distress syndrome and suggests an avenue for clinical intervention.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10921583     DOI: 10.1097/00003246-200007000-00050

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

1.  Apocynin attenuates ventilator-induced lung injury in an isolated and perfused rat lung model.

Authors:  Chi-Huei Chiang; Chiao-Hui Chuang; Shiou-Ling Liu; Tzong-Shyuan Lee; Yu Ru Kou; Haibo Zhang
Journal:  Intensive Care Med       Date:  2011-05-27       Impact factor: 17.440

2.  Glucose-6-phosphate dehydrogenase inhibition attenuates acute lung injury through reduction in NADPH oxidase-derived reactive oxygen species.

Authors:  A Nadeem; N O Al-Harbi; S F Ahmad; K E Ibrahim; N Siddiqui; M M Al-Harbi
Journal:  Clin Exp Immunol       Date:  2018-01-21       Impact factor: 4.330

3.  Febuxostat protects rats against lipopolysaccharide-induced lung inflammation in a dose-dependent manner.

Authors:  Alaa N A Fahmi; George S G Shehatou; Abdelhadi M Shebl; Hatem A Salem
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-28       Impact factor: 3.000

4.  Attenuation of hyperoxia-induced lung injury in rats by adrenomedullin.

Authors:  Wei Tao; Yu-Sheng Shu; Qian-Bing Miao; Ya-Bing Zhu
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

5.  Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.

Authors:  Danielle B Peterson; Tara Sander; Sushma Kaul; Bassam T Wakim; Brian Halligan; Simon Twigger; Kirkwood A Pritchard; Keith T Oldham; Jing-Song Ou
Journal:  Proteomics       Date:  2008-06       Impact factor: 3.984

6.  Proteome changes in human bronchoalveolar cells following styrene exposure indicate involvement of oxidative stress in the molecular-response mechanism.

Authors:  Nora Mörbt; Iljana Mögel; Stefan Kalkhof; Ralph Feltens; Carmen Röder-Stolinski; Jiang Zheng; Carsten Vogt; Irina Lehmann; Martin von Bergen
Journal:  Proteomics       Date:  2009-11       Impact factor: 3.984

7.  Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial cells.

Authors:  Sreerama Shetty; Thirunavukkarasu Velusamy; Rashmi S Shetty; Amarnath S Marudamuthu; Shwetha K Shetty; Galina Florova; Torry Tucker; Kathy Koenig; Praveenkumar Shetty; Yashodhar P Bhandary; Steven Idell
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-23       Impact factor: 6.914

8.  Disparate oxidant gene expression of airway epithelium compared to alveolar macrophages in smokers.

Authors:  Brendan J Carolan; Ben-Gary Harvey; Neil R Hackett; Timothy P O'Connor; Patricia A Cassano; Ronald G Crystal
Journal:  Respir Res       Date:  2009-11-17

9.  Levocetirizine Pretreatment Mitigates Lipopolysaccharide-Induced Lung Inflammation in Rats.

Authors:  Alaa N A Fahmi; George S G Shehatou; Hatem A Salem
Journal:  Biomed Res Int       Date:  2018-08-13       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.